Market cap data unavailable. We couldn't positively verify this ticker's market cap is under $500M. Verify independently before trading.
Nika Pharmaceuticals Inc.
- Market Cap
- Unavailable
- Price
- $0.51
- % Change (Daily % change from the live per-ticker quote feed.)
- +140.23%
- Volume
- 1.6K
About
Nika Pharmaceuticals Inc., a pharmaceutical enterprise headquartered in Henderson, Nevada, focuses on the creation of medications to address a broad spectrum of health conditions. Its research and development efforts target serious diseases including HIV/AIDS, hepatitis B and C, rheumatoid arthritis, cancer, and diabetes. The company's product line features antiviral treatments and nutritional supplements, notably providing a specialized thymus nuclear glycoprotein for the management of HIV. Originally established in 2000, the organization was previously known as Centennial Growth Equities Inc. before adopting its current name, Nika Pharmaceuticals, Inc., in May 2022.
Quick stats
Shares outstanding—
Computed float275.8M
Float / sharesUnknown
Key info
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001145604
AI Summary
AI-generated3mo agominorneutraloperations update
Nika Pharmaceuticals, Inc. (OTCQB: NIKA) June 2026 Update
Nika Pharmaceuticals reports it is in advanced negotiations with two parties regarding potential financing and strategic partnership.
The company states that upon securing funds, it will construct a pharmaceutical factory within four months and launch its lead asset, ITV-1, within 45 days thereafter.
No binding agreements, specific investor names, or funding amounts have been disclosed; the update serves as a general progress report for shareholders.
Red flags
- No binding financing agreement disclosed; 'advanced negotiations' are speculative
- Micro-cap OTCQB issuer with high execution risk
- Vague timeline dependent on undefined future funding